ECTRIMS 2024: An Overview MStranslate October 14, 2024 ECTRIMS, Events, Podcasts The MStranslate team recently attended the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) Congress 2024, held in Copenhagen, Denmark, between September 17 and 20. As he has...
Bile Acids: A Novel Multiple Sclerosis Therapy? MStranslate August 6, 2024 Research, Treatments Research Summary: Bile acid metabolites predict multiple sclerosis progression and supplementation is safe in progressive disease Researchers are constantly looking at novel approaches for the treatment of...
Long-term HSCT Outcomes in Norway MStranslate July 9, 2024 Research, Stem Cells, Treatments Research Summary: Autologous hematopoietic stem cell transplantation for multiple sclerosis: Long-term follow-up data from Norway Although not a new treatment approach, haematopoietic stem cell...
‘Wearing Off’ Of MS Treatments Between Doses MStranslate July 1, 2024 Research, Treatments Research Summary: The patient-reported wearing-off phenomenon with monoclonal antibody treatments for multiple sclerosis One of the major developments in the treatment of multiple sclerosis has been the...
Retinoic Acid and Calcitriol May Promote Remyelination MStranslate June 25, 2024 Remyelination, Research, Treatments Research Summary: The combined administration of LNC-encapsulated retinoic acid and calcitriol stimulates oligodendrocyte progenitor cell differentiation in vitro and in vivo after intranasal...
Announcement: MS Research Comms Collaboration MStranslate May 15, 2024 Cambridge, Collaboration, Research We are excited to announce that MStranslate has established a new science communication collaboration with the Cambridge Clinical Multiple Sclerosis Research Group, based at the University of Cambridge in...
Is Vitamin B12 Important in Multiple Sclerosis? MStranslate December 20, 2023 Fingolimod, Research, Vitamin B12 2 Comments Research Summary: FTY720 requires vitamin B12-TCN2-CD320 signaling in astrocytes to reduce disease in an animal model of multiple sclerosis The treatment of multiple sclerosis has improved greatly over the...
BTK Inhibitors in the Treatment of MS MStranslate December 12, 2023 Clinical Trials, Research, Treatments What is Bruton’s Tyrosine Kinase (BTK)? Bruton’s Tyrosine Kinase, or BTK, is an enzyme in the body that plays a role in the activity of B cells. B cells, which are important cells in the immune system,...
The MS Milan 2023 Podcast: Daily Episodes MStranslate November 16, 2023 Conferences, ECTRIMS, Podcasts Following the success of The ECTRIMS Podcast 2022 and its subsequent episodes throughout 2023, the European Committee for Treatment and Research in Multiple Sclerosis organisation once again invited our...
MS Milan 2023: Daily Research Summary Videos MStranslate October 19, 2023 ACTRIMS, ECTRIMS, Research 1 Comment MS Milan 2023 was the 9th Joint ECTRIMS-ACTRIMS Meeting, coordinated by the European Congress for the Treatment and Research Into Multiple Sclerosis (ECTRIMS) and the Americas Committee for Treatment and...